{{Rsnum
|rsid=989692
|Gene=MME
|Chromosome=3
|position=155083576
|Orientation=plus
|GMAF=0.41
|Gene_s=MME
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 23.9 | 47.8 | 28.3
| HCB | 63.5 | 35.0 | 1.5
| JPT | 63.7 | 30.1 | 6.2
| YRI | 14.4 | 52.1 | 33.6
| ASW | 16.1 | 53.6 | 30.4
| CHB | 63.5 | 35.0 | 1.5
| CHD | 57.8 | 39.4 | 2.8
| GIH | 54.5 | 38.6 | 6.9
| LWK | 20.4 | 44.4 | 35.2
| MEX | 39.7 | 41.4 | 19.0
| MKK | 34.6 | 53.2 | 12.2
| TSI | 26.5 | 62.7 | 10.8
| HapMapRevision=28
}}{{PMID Auto
|PMID=23838604
|Title=Genetic variants associated with angiotensin-converting enzyme inhibitor-associated angioedema
}}

{{PMID Auto
|PMID=15548496
|Title=Polymorphisms in neprilysin gene affect the risk of Alzheimer's disease in Finnish patients.
|OA=1
}}

{{PMID Auto
|PMID=25125048
|Title=Meta-analysis of the association between two neprilysin gene polymorphisms and Alzheimer's disease
}}
{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}